Najafian Hamideh, Pouresmaeil Omid, Meshkat Zahra, Aryan Ehsan, Falahi Jamal, Najafian Leyla, Farsiani Hadi
Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Sci Rep. 2025 Aug 27;15(1):31579. doi: 10.1038/s41598-025-16969-4.
Hypervirulent Klebsiella pneumoniae (hvKp) has emerged as a clinically significant pathogen that can cause severe infections, even in immunocompetent hosts. Unlike classical K. pneumoniae (cKp), hvKp exhibits enhanced virulence characterized by hypermucoviscosity and the presence of key genetic determinants. Its increasing detection in hospital settings, particularly in intensive care units (ICUs), raises concerns regarding nosocomial transmission and antibiotic resistance. A total of 187 K. pneumoniae isolates from patients at the Imam Reza Hospital, Mashhad, Iran, were screened phenotypically and genotypically. The hypermucoviscous phenotype was assessed using the string test and PCR was used to detect virulence genes (rmpA, rmpA2, and iucA). Antimicrobial susceptibility testing and extended-spectrum β-lactamase (ESBL) detection were conducted, and statistical analyses were performed to compare the hvKp and cKp isolates. hvKp accounted for 9.63% of all isolates. These strains were significantly associated with the presence of rmpA, rmpA2, and iucA genes. Although no statistically significant differences in antimicrobial resistance were observed between hvKp and cKp, the hvKp strains exhibited relatively lower resistance rates. A slightly higher but non-significant ESBL production rate was noted among the hvKp isolates. Diabetes and renal failure emerged as significant risk factors for hvKp infection, whereas age showed no such association. The detection of hvKp in ICU settings, coupled with its virulence potential and relative antibiotic susceptibility, underscores the urgent need for enhanced surveillance, infection control, and targeted antimicrobial stewardship. Future research should focus on the genomic evolution of hvKp and its interplay with host factors to develop effective prevention and treatment strategies.
高毒力肺炎克雷伯菌(hvKp)已成为一种具有临床意义的病原体,即使在免疫功能正常的宿主中也可引起严重感染。与经典肺炎克雷伯菌(cKp)不同,hvKp表现出以高黏液性和关键基因决定因素的存在为特征的增强毒力。其在医院环境中,特别是在重症监护病房(ICU)中的检出率不断增加,引发了对医院内传播和抗生素耐药性的担忧。对来自伊朗马什哈德伊玛目礼萨医院患者的187株肺炎克雷伯菌分离株进行了表型和基因型筛选。使用拉丝试验评估高黏液表型,并使用聚合酶链反应(PCR)检测毒力基因(rmpA、rmpA2和iucA)。进行了抗菌药物敏感性测试和超广谱β-内酰胺酶(ESBL)检测,并进行了统计分析以比较hvKp和cKp分离株。hvKp占所有分离株的9.63%。这些菌株与rmpA、rmpA2和iucA基因的存在显著相关。虽然在hvKp和cKp之间未观察到抗菌药物耐药性的统计学显著差异,但hvKp菌株的耐药率相对较低。在hvKp分离株中发现ESBL产生率略高但无统计学意义。糖尿病和肾衰竭成为hvKp感染的重要危险因素,而年龄则未显示出这种关联。在ICU环境中检测到hvKp,再加上其毒力潜力和相对抗生素敏感性,凸显了加强监测、感染控制和针对性抗菌药物管理的迫切需求。未来的研究应侧重于hvKp的基因组进化及其与宿主因素的相互作用,以制定有效的预防和治疗策略。